Exciting Data on Developing Drugs for Myelofibrosis

Over the past year, there has been continued progress in improving treatments for myelofibrosis. In this video, Dr. Claire Harrison, noted expert in the treatment of myeloproliferative conditions, shares updated news about  three-year data from the Comfort II study.  She shares information that is coming in showing an ongoing positive response to the treatment regimen with ruxolitinib without seeing many new or intolerable side effects. Watch now.